986 related articles for article (PubMed ID: 25607707)
1. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.
Sakamoto M; Sugimoto N; Kawabata H; Yamakawa E; Kodera N; Pillai R; Tatsumi Y
J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707
[TBL] [Abstract][Full Text] [Related]
2. Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis.
Bhatt V; Pillai R
J Pharm Sci; 2015 Jul; 104(7):2177-82. PubMed ID: 25940933
[TBL] [Abstract][Full Text] [Related]
3. Access of efinaconazole topical solution, 10%, to the infection site by spreading through the subungual space.
Elewski BE; Pollak RA; Pillai R; Olin JT
J Drugs Dermatol; 2014 Nov; 13(11):1394-8. PubMed ID: 25607708
[TBL] [Abstract][Full Text] [Related]
4. The low keratin affinity of efinaconazole contributes to its nail penetration and fungicidal activity in topical onychomycosis treatment.
Sugiura K; Sugimoto N; Hosaka S; Katafuchi-Nagashima M; Arakawa Y; Tatsumi Y; Jo Siu W; Pillai R
Antimicrob Agents Chemother; 2014 Jul; 58(7):3837-42. PubMed ID: 24752277
[TBL] [Abstract][Full Text] [Related]
5. Enhancing transungual delivery and spreading of efinaconazole under the nail plate through a unique formulation approach.
Kircik LH
J Drugs Dermatol; 2014 Dec; 13(12):1457-61. PubMed ID: 25607788
[TBL] [Abstract][Full Text] [Related]
6. The Presence of an Air Gap Between the Nail Plate and Nail Bed in Onychomycosis Patients: Treatment Implications for Topical Therapy.
Gupta AK; Pillai R
J Drugs Dermatol; 2015 Aug; 14(8):859-63. PubMed ID: 26267730
[TBL] [Abstract][Full Text] [Related]
7. Efinaconazole 10% topical solution for the topical treatment of onychomycosis of the toenail.
Lipner SR; Scher RK
Expert Rev Clin Pharmacol; 2015; 8(6):719-31. PubMed ID: 26325488
[TBL] [Abstract][Full Text] [Related]
8. Preparation and
Lee BC; Pangeni R; Na J; Koo KT; Park JW
Drug Deliv; 2019 Dec; 26(1):1167-1177. PubMed ID: 31738083
[TBL] [Abstract][Full Text] [Related]
9. Ciclopirox and Efinaconazole Transungual Permeation, Antifungal Activity, and Proficiency To Induce Resistance in Trichophyton rubrum.
Monti D; Mazzantini D; Tampucci S; Vecchione A; Celandroni F; Burgalassi S; Ghelardi E
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332076
[TBL] [Abstract][Full Text] [Related]
10. Topical treatment of onychomycosis with efinaconazole solution 10%.
Rich P
Cutis; 2013 Jun; 91(6):305-7. PubMed ID: 23837154
[TBL] [Abstract][Full Text] [Related]
11. Efficacy Coefficients Determined Using Nail Permeability and Antifungal Activity in Keratin-Containing Media Are Useful for Predicting Clinical Efficacies of Topical Drugs for Onychomycosis.
Matsuda Y; Sugiura K; Hashimoto T; Ueda A; Konno Y; Tatsumi Y
PLoS One; 2016; 11(7):e0159661. PubMed ID: 27441843
[TBL] [Abstract][Full Text] [Related]
12. Efinaconazole solution 10% for treatment of toenail onychomycosis in Latino patients.
Cook-Bolden FE; Lin T
Cutis; 2017 Apr; 99(4):286-289. PubMed ID: 28492600
[TBL] [Abstract][Full Text] [Related]
13. Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter, randomized, double-blind study.
Tschen EH; Bucko AD; Oizumi N; Kawabata H; Olin JT; Pillai R
J Drugs Dermatol; 2013 Feb; 12(2):186-92. PubMed ID: 23377392
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and Efficacy of Two Topical Therapeutic Agents for Onychomycosis.
Kawai M
Med Mycol J; 2019; 60(3):71-74. PubMed ID: 31474693
[TBL] [Abstract][Full Text] [Related]
15. Efinaconazole topical solution, 10%: the development of a new topical treatment for toenail onychomycosis.
Pollak RA
J Am Podiatr Med Assoc; 2014 Nov; 104(6):568-73. PubMed ID: 25514267
[TBL] [Abstract][Full Text] [Related]
16. Efinaconazole solution 10%: topical antifungal therapy for toenail onychomycosis.
Tosti A
Cutis; 2013 Oct; 92(4):203-8. PubMed ID: 24195094
[TBL] [Abstract][Full Text] [Related]
17. Efinaconazole: a new topical treatment for onychomycosis.
Gupta AK; Simpson FC
Skin Therapy Lett; 2014; 19(1):1-4. PubMed ID: 24570290
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of efinaconazole 10% solution for treatment of mild to moderate onychomycosis: a pooled analysis of two phase 3 randomized trials.
Gupta AK; Elewski BE; Sugarman JL; Ieda C; Kawabata H; Kang R; Pillai R; Olin JT; Watanabe S
J Drugs Dermatol; 2014 Jul; 13(7):815-20. PubMed ID: 25007364
[TBL] [Abstract][Full Text] [Related]
19. Efinaconazole topical solution, 10%: the benefits of treating onychomycosis early.
Rich P
J Drugs Dermatol; 2015 Jan; 14(1):58-62. PubMed ID: 25607909
[TBL] [Abstract][Full Text] [Related]
20. Report of a case of a dermatophytoma successfully treated with topical efinaconazole 10% solution.
Cantrell W; Canavan T; Elewski B
J Drugs Dermatol; 2015 May; 14(5):524-6. PubMed ID: 25942674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
